Article

ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients

2020-02-24

Abstract excerpt

<title>Abstract</title> <p>Aldehyde dehydrogenase 1A3 (ALDH1A3) has been implicated in the survival and proliferation of prostate cancer cells. We retrospectively reviewed our patients with advanced disease on adjuvant hormonal therapy after prostatectomy. Time to castration resistance stage was documented. And Immunohistochemistry analysis for ALDH1A3 was performed for those patient samples on tissue microarray....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7763f0f2-5a73-5b37-9126-647919ba1416
DOI: 10.21203/rs.2.21612/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ALDH1A3 serves as a predictor for castration resistance in prostate cancer patientsDOI 10.21203/rs.2.21612/v2Read

The distinct role of ALDH1A1 and ALDH1A3 in the regulation of prostate cancer metastasesSemantic proximity Read

Identification of key molecules for castration resistance prostate cancer by bioinformatic analysisSemantic proximity Read

Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells <i>in vitro</i>Semantic proximity Read

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancerSemantic proximity Read

Identification of Hub Gene and Potential Drugs for Enzalutamide Resistant Castration-Resistant Prostate Cancer Depend On Bioinformatics AnalysisSemantic proximity Read

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration- resistant prostate cancer by bioinformatic analysisSemantic proximity Read

Gene expression signature of castrate resistant prostate cancerSemantic proximity Read

Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivoSemantic proximity Read

Mechanisms of resistance to androgen deprivation therapy in prostate cancer.Semantic proximity Read

Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity Read

The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistanceSemantic proximity Read